会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • HIGH WATT TYPE CERAMIC METAL HALIDE LAMP ILLUMINATION DEVICE
    • 高温型陶瓷金属卤化物灯照明装置
    • US20140354175A1
    • 2014-12-04
    • US14344723
    • 2012-08-04
    • Masashi IidaAkiyoshi MaeharaMakoto Ohkahara
    • Masashi IidaAkiyoshi MaeharaMakoto Ohkahara
    • H05B41/24
    • H05B41/24H01J61/827H01J61/92H05B41/042H05B41/2885H05B41/2928Y02B20/202
    • A high watt type ceramic metal halide lamp illumination device is provided. The device comprises: ballast receiving a primary input voltage and outputting a secondary voltage, and a lamp having a plurality of arc tubes electrically connected in series inside an outer bulb. The lamp is lighted by receiving the secondary voltage output from the ballast. The secondary voltage output from the ballast has a waveform that at least satisfies a maximum-value to effective-value ratio (Vmax/Veff) of greater than 20.5. When using two 360 W arc tubes of a popular type by electrically connecting the two in series instead of a 700 W arc tube of a high-watt type, for example, it is preferable to use a triangular waveform AC voltage that satisfies 260≦Veff(triangular waveform) when expressed by the effective-value, and 500 V≦Vmax(triangular waveform) when expressed by the maximum-value.
    • 提供高瓦特型陶瓷金属卤化物灯照明装置。 该装置包括:镇流器接收初级输入电压并输出次级电压;以及灯,其具有串联连接在外灯泡内的多个电弧管。 通过接收从镇流器输出的二次电压来点亮灯。 从镇流器输出的次级电压具有至少满足最大值至有效值比(Vmax / Veff)大于20.5的波形。 例如,当使用两个串联的两个360W的电弧管,而不是例如高瓦特的700瓦的电弧管时,通常使用两个串联的电弧管,而不是使用满足260&nlE的三角波形AC电压; Veff (三角波形),当由最大值表示时,由有效值表示500 V≦̸ Vmax(三角波形)。
    • 3. 发明授权
    • Certain chroman derivatives useful for treating symptoms caused by
contraction of smooth muscles, circulatory diseases or epilepsy
    • 某些苯并二氢吡喃衍生物可用于治疗由平滑肌,循环系统疾病或癫痫的收缩引起的症状
    • US5296492A
    • 1994-03-22
    • US893403
    • 1992-06-03
    • Akira ShiozawaAtsuro InubushiKazuhisa NaritaYukihiro SagawaMakoto HosonoMasashi Iida
    • Akira ShiozawaAtsuro InubushiKazuhisa NaritaYukihiro SagawaMakoto HosonoMasashi Iida
    • A61K31/35A61K31/353A61K31/44A61K31/4433A61P9/00A61P21/00C07D213/50C07D213/64C07D311/20C07D311/68C07D405/04C07F7/18C07D407/04C07F7/02A61K31/695
    • C07D405/04C07F7/1856
    • A chroman derivative represented by the following general formula [1]: ##STR1## wherein R.sub.1 represents cyano group, nitro group, halogenomethyl group or --SO.sub.2 --X group (X represents lower alkyl group having 1-6 carbon atoms or aryl group); R.sub.2 represents hydrogen atom or OA group (A represents hydrogen atom, nitro group, lower acyl group having 1-6 carbon atoms, arylcarbonyl group, lower alkylsulfonyl group having 1-6 carbon atoms, arylsulfonyl group, arylalkyl group, tetrahydropyranyl group, lower alkoxycarbonyl group having 1-6 carbon atoms, arylalkoxycarbonyl group or silyl derivative group); R.sub.3 singly represents a hydrogen atom; or R.sub.3 forms a bond jointly with R.sub.2 ; and R.sub.4, R.sub.5, R.sub.6 and R.sub.7 each represent hydrogen atom, vinyl group, formyl group, --Y--(OA).sub.n group (Y represents straight or branched chain alkylene group having 1-6 carbon atoms or lower alkenyl group having 1-6 carbon atoms, A is as defined above, and n represents an integer of 1-3.The compound of this invention is expected to be effectively usable as an agent for treatment of various symptoms due to the contraction of smooth muscles, for treatment of the diseases of the circulatory system and for treatment of epilepsy.
    • 由下列通式(1)表示的苯并二氢吡喃衍生物:(*化学结构*)(1)其中R1表示氰基,硝基,卤代甲基或-SO2-X基(X表示具有1-6个碳原子的低级烷基 原子或芳基); R2表示氢原子或OA基(A表示氢原子,硝基,具有1-6个碳原子的低级酰基,芳基羰基,具有1-6个碳原子的低级烷基磺酰基,芳基磺酰基,芳基烷基,四氢吡喃基,低级烷氧基羰基 具有1-6个碳原子的基团,芳基烷氧基羰基或甲硅烷基衍生物基团); R3单独表示氢原子; 或R3与R2一起形成键; 和R 4,R 5,R 6和R 7各自表示氢原子,乙烯基,甲酰基,-Y-(OA)n基(Y表示具有1-6个碳原子的直链或支链亚烷基或具有1-6个碳原子的低级链烯基 碳原子,A如上所定义,n表示1-3的整数。预期本发明化合物可有效地用作治疗由于平滑肌收缩引起的各种症状的药剂,用于治疗 循环系统疾病和治疗癫痫。
    • 4. 发明授权
    • Fused solid electrolytic capacitor
    • 熔融固体电解电容器
    • US4935848A
    • 1990-06-19
    • US238554
    • 1988-08-30
    • Masayuki YamaneMasashi Iida
    • Masayuki YamaneMasashi Iida
    • H01G9/00
    • H01G9/0003
    • A fused solid electrolytic capacitor comprises a six sided body having a pair of spaced parallel sides, one of which will be positioned next to any mounting structure which supports the capacitor. One end of a fuse wire may be connected to either of the spaced parallel sides. The other end of the fuse wire extends through an open passageway in an insulating block to a cathode electrode, thereby giving the fuse wire a fixed length. This way there is no danger that the fuse wire may short circuit along its length to either the capacitor body or the cathode electrode. A result is a smaller capacitor which may be manufactured with a greater harvest yield, as compared to the size and yield of similar prior art fused solid electrolytic capacitors.
    • 固体电解电容器设有连接在阴极层和外部阴极端子(23)之间的熔丝元件(31),所述阴极层覆盖电容器主体(1)的底部和侧面,阴极端子(23) 与底表面间隔开,熔丝元件(31)从阴极端子(23)延伸到电容器主体(1)的侧表面,并且整个布置被封装在绝缘材料(51)中,熔丝 元件(31)优选地嵌入弹性弹簧(43)中。
    • 6. 发明授权
    • Naphthyridine deratives or salts thereof
    • 萘啶衍生物或其盐
    • US06294547B1
    • 2001-09-25
    • US09446452
    • 1999-12-21
    • Hiroko OkaMasashi IidaYoshitaka SatoMaki Honda
    • Hiroko OkaMasashi IidaYoshitaka SatoMaki Honda
    • C07D47104
    • C07D471/04
    • A novel naphthyridine compound represented by the general formula (1): wherein R1, R2 and R3 are independently a hydrogen atom, a lower alkyl group or the like, or R1 and R2, or R2 and R3, when taken together, form a cyclic group; each of X and Y is a methylene or ethylene group; Z is a phenyl group, a substituted phenyl group or the like; A is a hydrogen atom, a lower alkyl group or the like; and G is an acyl group, shows antagonism for tachykinin receptors and is useful as a prophylactic or therapeutic agent for diseases for which the tachykinin receptors are considered to be responsible. A specific example of such a compound is 2-[(−)-4-(N-benzoyl-N-methyl)amino-3-(3,4-dichlorophenyl)butyl]-10-acetylamino-1,2,3,4-tetrahydro-benzo[b][1,6]naphthyridine.
    • 由通式(1)表示的新颖的萘啶化合物:其中R1,R2和R3独立地为氢原子,低级烷基等,或R1和R2,或R2和R3,当一起形成环状 组; X和Y各自为亚甲基或亚乙基; Z是苯基,取代的苯基等; A是氢原子,低级烷基等; 并且G是酰基,表示对速激肽受体的拮抗作用,并且可用作对速激肽受体被认为负责的疾病的预防或治疗剂。 这种化合物的具体实例是2 - [( - ) - 4-(N-苯甲酰基-N-甲基)氨基-3-(3,4-二氯苯基)丁基] -10-乙酰氨基-1,2,3, 4-四氢 - 苯并[b] [1,6]萘啶。